Basel Medical Group (BMGL) Income Statement (2025 - 2026)
Income Statement report data from Sep 30, 2025 to Mar 31, 2026 for Basel Medical Group (BMGL) in SGD with ability to convert in USD.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
| Mar 31, 2026 | Sep 30, 2025 | |
|---|---|---|
Revenue and COGS | ||
Total Revenue | 8.24M (+36.20%) | 6.05M |
Cost Of Revenue | 9.22M (+70.43%) | 5.41M |
Costof Goods And Services Sold | 9.22M (+70.43%) | 5.41M |
Gross Profit | -980.00K | 640K |
Operating Expenses | ||
Operating Expenses | 1.93M (-14.60%) | 2.26M |
Depreciation And Amortization | 2.05M (+156.25%) | 800K |
Operating Income | ||
Operating Income | -2.91M (+80.75%) | -1.61M |
Ebit | -2.91M (+80.75%) | -1.61M |
EBITDA | -860.00K (+4.88%) | -820.00K |
Other Income / Expenses | ||
Interest Expense | 220K (+120.00%) | 100K |
Net Income | ||
Income Before Tax | 340K | -10.34M |
Income Tax Expense | 180K | -400.00K |
Net Income | 270K | -9.94M |